Fri, Apr 18, 2014, 1:46 PM EDT - U.S. Markets closed for Good Friday


% | $
Quotes you view appear here for quick access.

BioLineRx, Ltd. (BLRX) Message Board

  • garsden garsden Mar 22, 2013 8:10 AM Flag

    BioLineRx PT Lowered to $7.00 (BLRX)

    Analysts at Aegis lowered their price target on shares of BioLineRx (NASDAQ: BLRX) from $11.00 to $7.00 in a research report issued to clients and investors on Wednesday. The firm currently has a “buy” rating on the stock.

    BioLineRx (NASDAQ: BLRX) traded down 53.02% on Wednesday, hitting $1.7899. BioLineRx has a 52-week low of $2.20 and a 52-week high of $5.10. The stock’s 50-day moving average is currently $3.9. The company’s market cap is $39.5 million.

    BioLineRX Ltd. is an Israel-based company engaged in identifying and following the critical pathway to commercialization of therapeutic compounds.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
2.04+0.01(+0.49%)Apr 17 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Weibo Corporation
NasdaqGSThu, Apr 17, 2014 4:00 PM EDT
WisdomTree Investments, Inc.
NasdaqGSThu, Apr 17, 2014 4:00 PM EDT